Co-Founder and CEO @ Rosa Bio (September 2024 - May 2025)
Vice President of Product Strategy @ (June 2023 - July 2024)
Senior Scientific Advisor, NGS @ (November 2022 - May 2023)
Global market development and applications @ (January 2022 - November 2022)
General Manager, NGS @ (January 2020 - January 2022)
Director of NGS Business Development @ (October 2017 - January 2020)
Director of NGS Scientific Applications @ (March 2015 - September 2017)
Director of Applications Development @ (January 2013 - March 2015)
Senior Director of Molecular Biology and Sequencing @ GenapSys (June 2012 - January 2013)
Director, Molecular Biology and Sequencing @ (July 2010 - June 2012)
Manager of Sequencing Development @ (May 2004 - May 2010)
Graduate Student @ (January 1999 - January 2004)
Mirna Jarosz Education
Massachusetts Institute of Technology
PhD (Chemistry)
1999-2004
University of Washington
B.S. (Chemistry)
1995-1999
Mirna Jarosz Skills
Assay Development
Biochemistry
Bioinformatics
Biomarkers
Biotechnology
Cancer
Chemistry
DNA
DNA Sequencing
Drug Discovery
Genetics
Genomics
Life Sciences
Lifesciences
Microscopy
Molecular Biology
Molecular Diagnostics
PCR
Personalized Medicine
Purification
R&D
Research and Development (R&D)
Sequence Analysis
Sequencing
Start-ups
Technology Transfer
Validation
qPCR
Start Ups
Applications
Teaching
miRNA
NGS
Microsoft Word
Marketing
Microsoft Excel
Research And Development R&D
Research and Development
Mirna Jarosz Summary
Mirna Jarosz, based in California, United States, is currently a Chief Executive Officer at LiquidCell Dx. Mirna Jarosz brings experience from previous roles at LiquidCell Dx, Various, Rosa Bio and Ultima Genomics. Mirna Jarosz holds a 1999 - 2004 PhD in Chemistry @ Massachusetts Institute of Technology. With a robust skill set that includes Assay Development, Biochemistry, Bioinformatics, Biomarkers, Biotechnology and more. Mirna Jarosz has 2 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Mirna Jarosz?
Find contact details for 700 million professionals.